Are IPRs and patents the real barriers to COVID-19 vaccine supplies?
<p>In less than a year since the WHO’s declaration of COVID-19 as a global pandemic, 13 vaccines against COVID-19 have been approved in at least one jurisdiction. However, new challenges have arisen, mostly surrounding the global distribution and access to these vaccines, particularly for low...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
ElectronicPublications.org Ltd
2021
|